HemaSphere (Jun 2022)
P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG-TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML-001 TRIAL OF ORAL AZACITIDINE
- A. H. Wei,
- H. Döhner,
- H. Sayar,
- F. Ravandi,
- P. Montesinos,
- H. Dombret,
- D. Selleslag,
- K. Porkka,
- J.-H. Jang,
- B. Skikne,
- C. Beach,
- T. Prebet,
- G. Zhang,
- A. Risueño,
- M. Ugidos Guerrero,
- W. L. See,
- D. Menezes,
- G. J. Roboz
Affiliations
- A. H. Wei
- 1 Department of Clinical Haematology, Alfred Hospital, and the Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
- H. Döhner
- 2 Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany
- H. Sayar
- 3 Indiana University Cancer Center, Indianapolis
- F. Ravandi
- 4 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America
- P. Montesinos
- 5 Hospital Universitario y Politécnico La Fe, Valencia, Spain
- H. Dombret
- 6 Hematology, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris (AP-HP), and Institut de Recherche Saint-Louis, Université de Paris, Paris, France
- D. Selleslag
- 7 AZ Sint-Jan Brugge-Oostende AV, Bruges, Belgium
- K. Porkka
- 8 HUS Comprehensive Cancer Center, Hematology Research Unit Helsinki and iCAN Digital Precision Cancer Center Medicine Flagship, University of Helsinki, Helsinki, Finland
- J.-H. Jang
- 9 Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
- B. Skikne
- 10 Bristol Myers Squibb, Princeton, United States of America
- C. Beach
- 10 Bristol Myers Squibb, Princeton, United States of America
- T. Prebet
- 10 Bristol Myers Squibb, Princeton, United States of America
- G. Zhang
- 10 Bristol Myers Squibb, Princeton, United States of America
- A. Risueño
- 11 BMS Center for Innovation and Translational Research Europe (CITRE, a Bristol-Myers Squibb Company), Seville, Spain
- M. Ugidos Guerrero
- 11 BMS Center for Innovation and Translational Research Europe (CITRE, a Bristol-Myers Squibb Company), Seville, Spain
- W. L. See
- 10 Bristol Myers Squibb, Princeton, United States of America
- D. Menezes
- 10 Bristol Myers Squibb, Princeton, United States of America
- G. J. Roboz
- 12 Weill Cornell Medicine and New York Presbyterian Hospital, New York, United States of America
- DOI
- https://doi.org/10.1097/01.HS9.0000844880.16190.70
- Journal volume & issue
-
Vol. 6
pp. 397 – 398
Abstract
No abstracts available.